Literature DB >> 7535312

Serological reactivity and viral genotypes in hepatitis C virus infection.

F Maggi1, M L Vatteroni, M Pistello, C M Avio, N Cecconi, F Panicucci, M Bendinelli.   

Abstract

Patients infected with hepatitis C virus (HCV) were examined with four commercial HCV immunoblotting assays and for anti-GOR antibody to ascertain whether serological findings varied with the genotype of the infecting virus. The results indicate that patients infected with different HCV genotypes tend to show different immunoblotting profiles, mainly due to a low prevalence of antibodies to the viral region NS4 in patients infected with genotypes III and IV. Differences were more evident with second- than with third-generation assays. Patients infected with genotype IV exhibited a lower prevalence of anti-GOR antibody than patients infected with other genotypes.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7535312      PMCID： PMC227910          DOI： 10.1128/jcm.33.1.209-211.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Serological responses to infection with three different types of hepatitis C virus.

Authors:  S W Chan; P Simmonds; F McOmish; P L Yap; R Mitchell; B Dow; E Follett
Journal:  Lancet       Date:  1991-11-30       Impact factor: 79.321

2.  An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen.

Authors:  S Mishiro; K Takeda; Y Hoshi; A Yoshikawa; T Gotanda; Y Itoh
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

3.  Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process.

Authors:  S Mishiro; Y Hoshi; K Takeda; A Yoshikawa; T Gotanda; K Takahashi; Y Akahane; H Yoshizawa; H Okamoto; F Tsuda
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

4.  A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus.

Authors:  K Muraiso; M Hijikata; S Ohkoshi; M J Cho; M Kikuchi; N Kato; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

5.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

6.  Immune response to GOR, a marker for non-A, non-B hepatitis and its correlation with hepatitis C virus infection.

Authors:  S U Mehta; S Mishiro; K Sekiguchi; T Leung; G J Dawson; L M Pendy; D A Peterson; S G Devare
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

7.  Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

Authors:  H Okamoto; H Tokita; M Sakamoto; M Horikita; M Kojima; H Iizuka; S Mishiro
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

8.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.

Authors:  K Yoshioka; S Kakumu; T Wakita; T Ishikawa; Y Itoh; M Takayanagi; Y Higashi; M Shibata; T Morishima
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

10.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948
View more
  7 in total

1.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Genotypic distribution of hepatitis C virus in different regions of Thailand.

Authors:  D Kanistanon; M Neelamek; T Dharakul; S Songsivilai
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

Review 3.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  A serotyping assay for hepatitis C virus in Southeast Asia.

Authors:  S Songsivilai; D Kanistanon; T Dharakul
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

5.  Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies.

Authors:  Juan A Quiroga; Inmaculada Castillo; Javier Bartolomé; Vicente Carreño
Journal:  Clin Vaccine Immunol       Date:  2007-08-15

Review 6.  Advances in the Diagnosis and Monitoring of Hepatitis C Virus Infection.

Authors:  Marco Ciotti; Cartesio D'Agostini; Aldo Marrone
Journal:  Gastroenterology Res       Date:  2013-10-31

7.  Partial nucleotide sequencing of six subtype 2c hepatitis C viruses detected in Italy.

Authors:  G Cammarota; F Maggi; M L Vatteroni; L Da Prato; L Barsanti; M Bendinelli; M Pistello
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.